The European Medicines Agency informs physicians and patients that interactions were found between boceprevir (VICTRELIS used in the treatment of hepatitis C) and certain protease inhibitors of the AIDS virus, namely atazanavir (REYATAZ), darunavir (PREZISTA) boosted by ritonavir (Norvir) and lopinavir combined with ritonavir (KALETRA). Some associations are no longer recommended and monitoring is required during the concomitant administration of these medicines.
More information on the EMA website.
Contact